Skip to main content

Day: December 14, 2019

Vanstar Announces a Correction Regarding a Recent Release Concernning the Grant of Stock Options.

THIS PRESS RELEASE CANNOT BE DISTRIBUTED TO THE AMERICAN PRESS SERVICES FOR UNITED STATES RELEASE.LA PRAIRIE, Quebec, Dec. 14, 2019 (GLOBE NEWSWIRE) — Vanstar Mining Resources management announces that it has granted to its officers and directors a total of 1,580,000 options instead of the 2 million previously announced in the press release dated of December 11, 2019. These options can be exercised no later than December 10, 2024, at a price of $0.35 per share.The TSX Venture Exchange and its regulator (as this term is defined in the TSX Venture Exchange policies) accept no responsibility for the adequacy or accuracy of its content.Sources:Sébastien Plouffe, VP – Public Relationssebas.plouffe@gmail.com  514-947-2272Gary Claytens, VP – Western Corporate Development 604-761-3233info@rvanstar.comwww.vanstar...

Continue reading

Vanstar annonce une rectification sur l’octroi d’options récemment annoncé

CE COMMUNIQUÉ NE PEUT PAS ÊTRE DISTRIBUÉ AUX SERVICES DE FIL DE PRESSE AMÉRICAINS POUR FINS DE DIFFUSION AUX ÉTATS-UNIS.LA PRAIRIE, Québec, 14 déc. 2019 (GLOBE NEWSWIRE) — La direction de Ressources Minières Vanstar Inc annonce avoir octroyé à ses dirigeants et administrateurs un nombre total de 1,580,000 options au lieu des 2 millions préalablement annoncés lors du communiqué de presse du 11 décembre dernier. Ces options peuvent être exercées au plus tard le 10 décembre 2024, au prix de 0,35 $ par action.La Bourse de croissance TSX ainsi que son fournisseur de services de régulation ( tel que ce terme est défini dans les politiques de la bourse de croissance du TSX ) n’acceptent aucune responsabilité...

Continue reading

Kommuniké från SkiStars årsstämma

Vid årsstämma i SkiStar AB (publ) idag den 14 december 2019 fattades beslut om följande.Utdelning om 3:50 kronor per aktie (3:50). Avstämningsdag den 17 december 2019.Till styrelseledamöter omvaldes Eivor Andersson, Lena Apler, Sara Karlsson och Fredrik Paulsson samt nyvaldes Lars-Göran Dahl, Gunilla Rudebjer och Anders Sundström.Till styrelseordförande valdes Eivor Andersson.Styrelsearvodet fastställdes, inklusive utskottsarvoden, till totalt 2 120 000 kronor (2018: 1 500 000), varav 500 000 kronor (400 000) till styrelsens ordförande och 220 000 kronor (200 000) vardera till övriga ledamöter som inte är anställda i bolaget. Ledamöter i revisionsutskottet ska erhålla ett arvode om totalt 200 000 kronor (200 000),...

Continue reading

Myriad’s Polygenic Risk Score Personalizes Risk of Breast Cancer for Woman with a Genetic Mutation in Important Breast Cancer Genes

SALT LAKE CITY, Dec. 14, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that results of a new validation study of the company’s polygenic risk score (PRS) for breast cancer were presented at the 2019 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Tx.  The key finding is that the PRS significantly improves the precision and accuracy of breast cancer risk estimates for women of European ancestry who have pathogenic variants (PV) in high- and moderate-penetrance breast cancer genes.“Our goal is to help women understand their risk of breast cancer so that they can take steps to live longer, healthier lives.  Women who have a family history of breast cancer should consider hereditary cancer testing with the myRisk Hereditary Cancer test,”...

Continue reading

NXT Energy Solutions Inc. Issues Direction to Alberta Green Ventures Limited Partnership Regarding Loan Repayment

CALGARY, Alberta, Dec. 13, 2019 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX:SFD; OTC QB:NSFDF) has issued a direction (the “Direction”) to Alberta Green Ventures Limited Partnership (“AGV”) to deliver for cancellation the number of common shares in the capital of the Company (“Common Shares”) held by AGV that is equivalent to the US$250,000.00 principal amount (the “Principal Amount”) previously loaned by the Company to AGV, the price per Common Share being the volume weighted average trading price of the Common Shares as reported and traded on the Toronto Stock Exchange for the five (5) trading days immediately preceding the date of repayment, and to pay by wire transfer or other immediately available funds all accrued and unpaid...

Continue reading

Annual Changes to the NASDAQ Biotechnology Index

NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq:NDAQ) today announced the results of the annual evaluation of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 23, 2019.The following 40 securities will be added to the Index:The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).As a result of the evaluation, the following 36 securities will be removed from the Index:About Nasdaq Global IndexesNasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families...

Continue reading

Annual Changes to the NASDAQ-100 Index

NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the results of the annual evaluation of the NASDAQ-100 Index® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 23, 2019.The following six companies will be added to the Index: ANSYS, Inc. (Nasdaq: ANSS), CDW Corporation (Nasdaq: CDW), Copart, Inc. (Nasdaq: CPRT), CoStar Group, Inc. (Nasdaq: CSGP), Seattle Genetics, Inc. (Nasdaq: SGEN), Splunk Inc. (Nasdaq: SPLK).The NASDAQ-100 Index is composed of the 100 largest non-financial companies listed on The NASDAQ Stock Market® and dates to January 1985 when it was launched along with the NASDAQ Financial-100 Index®, which is comprised of the 100 largest financial stocks on NASDAQ®. These indexes act as benchmarks for financial products such as options, futures, and funds....

Continue reading

Rivers Casino Des Plaines Opens New Sports Bar and Expands Gaming Floor

DES PLAINES, Ill., Dec. 13, 2019 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) and Rush Street Gaming announced today that their joint venture, Rivers Casino Des Plaines, has opened its new 4,840 square foot state-of-the-art BetRivers SportsBar. The BetRivers SportsBar features a 47-foot-wide ultra HD LED video wall and ten 86-inch and four 75-inch HD televisions placed throughout, offering patrons a panoramic view of live sports events. The new bar will also have a full service island bar with seating for 32, 26 bar-top video poker games, 32 leather lounge chairs and additional table seating options.The BetRivers SportsBar space was designed to provide an ultra-luxury viewing experience for Chicago’s sports fans looking for an engaging game-day experience and will eventually be home to the casino’s sports...

Continue reading

Athenex 宣佈,新的口服紫杉醇與靜脈輸注的紫杉醇相比下,對轉移性乳癌治療具有更高的反應和更低的神經病變。

在第三期臨床試驗中,口服紫杉烷首次顯示其反應率和整體生存率高於靜脈輸注紫杉醇研究數據將在 2019 年聖安東尼奧乳癌研討會 (SABCS) 以口述方式報告紐約水牛城, Dec. 14, 2019 (GLOBE NEWSWIRE) — 致力於研究、開發和商業化治療癌症新型療法的全球生物製藥公司 Athenex, Inc. (Nasdaq: ATNX) 今天宣佈來自一項關鍵的第三期臨床試驗結果。該研究結果顯示,用於治療轉移性乳癌的口服紫杉醇和 encequidar 與靜脈輸注紫杉醇相比,具有更高的反應性和生存率,其神經病變的發生率和嚴重性亦顯著較低。請在這裡查看網上摘要 GS6-01,以瞭解有關研究結果的詳情。Athenex 醫療總裁 Rudolf Kwan 博士說:「與靜脈輸注紫杉醇相比,用於治療轉移性乳癌的口服紫杉醇和 encequidar 是第一種口服紫杉在第三期研究中顯示出統計學上的顯著改善回應率和中位數總生存率,而神經病變的發生率和嚴重性亦顯著較低。我們相信這些數據表示口服紫杉醇和 encequidar 可為轉移性乳癌患者的治療提供重大進展。」有關結果今天將於 2019 年聖安東尼奧乳癌研討會 (SABCS) 第 6 節大會以口述方式報告,舉行時間為下午 3:15 (中部時間),地點為德克薩斯州聖安東尼奧市亨利巴博薩岡薩雷斯會議中心 3 號大堂廳。結果將於上午 7:30  (中部時間)在 SABCS 官方新聞發佈會上公佈。Orascovery 平台最初由 Hanmi Pharmaceuticals 開發,除了 Hanmi 保留了韓國的使用權外,它獨家授予 Athenex 全球所有主要地區的使用權。關於 Athenex, Inc.創於 2003 年,Athenex, Inc. 是一家臨床階段的國際生物製藥公司,亦致力成為研究、開發及商業化下一代癌症治療藥物的領導者。Athenex 下設三個平台,分別為腫瘤創新平台、商業平台和全球供應鏈平台。公司現有的臨床產品系列源自四個不同平台的科技:(1)...

Continue reading

Update: Planned Power Shutoffs Are Endangering Californians

SAN DIEGO, Dec. 13, 2019 (GLOBE NEWSWIRE) — NEOVOLTA INC. (OTCQB: NEOV) – California’s recent power shutoffs, unprecedented in scale, were intended to prevent power lines from sparking wildfires. Millions of residents were plunged into darkness and chaos, for several days in some cases. Schools and businesses were closed, and the financial impact could be in the billions. Even worse, these power shutoffs pose a serious risk to some of the most vulnerable Californians.Without electrical power, people are left without access to vital life-supporting and life-enhancing equipment, medications requiring refrigeration may be at risk, and mobility devices may not be able to be recharged. California now faces a longer and more intense fire season fueled by hot, dry winds. All three of its utility giants—Pacific Gas and Electric, Southern...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.